AGL 38.00 Increased By ▲ 0.01 (0.03%)
AIRLINK 205.00 Decreased By ▼ -5.38 (-2.56%)
BOP 9.25 Decreased By ▼ -0.23 (-2.43%)
CNERGY 6.35 Decreased By ▼ -0.13 (-2.01%)
DCL 8.69 Decreased By ▼ -0.27 (-3.01%)
DFML 40.26 Increased By ▲ 1.89 (4.93%)
DGKC 94.10 Decreased By ▼ -2.82 (-2.91%)
FCCL 35.30 Decreased By ▼ -1.10 (-3.02%)
FFBL 88.94 No Change ▼ 0.00 (0%)
FFL 14.95 No Change ▼ 0.00 (0%)
HUBC 127.76 Decreased By ▼ -2.93 (-2.24%)
HUMNL 13.22 Decreased By ▼ -0.07 (-0.53%)
KEL 5.33 Decreased By ▼ -0.17 (-3.09%)
KOSM 6.90 Decreased By ▼ -0.03 (-0.43%)
MLCF 43.50 Decreased By ▼ -1.28 (-2.86%)
NBP 58.69 Decreased By ▼ -0.38 (-0.64%)
OGDC 224.00 Decreased By ▼ -6.13 (-2.66%)
PAEL 38.16 Decreased By ▼ -1.13 (-2.88%)
PIBTL 8.30 Decreased By ▼ -0.01 (-0.12%)
PPL 196.75 Decreased By ▼ -3.60 (-1.8%)
PRL 38.25 Decreased By ▼ -0.63 (-1.62%)
PTC 26.02 Decreased By ▼ -0.86 (-3.2%)
SEARL 101.10 Decreased By ▼ -2.53 (-2.44%)
TELE 8.32 Decreased By ▼ -0.13 (-1.54%)
TOMCL 34.70 Decreased By ▼ -0.55 (-1.56%)
TPLP 13.25 Decreased By ▼ -0.27 (-2%)
TREET 24.26 Decreased By ▼ -0.75 (-3%)
TRG 63.68 Decreased By ▼ -0.44 (-0.69%)
UNITY 34.45 Decreased By ▼ -0.07 (-0.2%)
WTL 1.73 Decreased By ▼ -0.05 (-2.81%)
BR100 12,046 Decreased By -50.7 (-0.42%)
BR30 37,430 Decreased By -285.2 (-0.76%)
KSE100 110,972 Decreased By -1443.1 (-1.28%)
KSE30 35,006 Decreased By -502.4 (-1.41%)

The US is fast-tracking the anti-malarial drug chloroquine for use as a treatment against the new coronavirus, President Donald Trump said Thursday.
"We're going to be able to make that drug available almost immediately, and that's where the FDA (Food and Drug Administration) has been so great," Trump told reporters. "They've gone through the approval process - it's been approved. They took it down from many, many months to immediate. So we're going to be able to make that drug available by prescription."
But the FDA Commissioner Stephen Hahn later indicated that, while the drug has not yet been formally approved, access to it was being expanded so that authorities could gather more data.
This is known as "compassionate use."
"If there is an experimental drug that is potentially available, a doctor could ask for that drug to be used in a patient. We have criteria for that and very speedy approval for that," said Hahn.

Copyright Agence France-Presse, 2020

Comments

Comments are closed.